Home > Listed Companies Info. > Main Board Companies

:::

:::Listed Companies > Listed Companies Info. > Main Board Companies > Listed Company Profile

General Stock Board Listed Company Profile

Code:

Industry:

Local/Foreign Company:

6617 Gongwin

中文

Company Profile

Chairman

CEO

Spokesperson

Tel

Address

Date of Listing (Regular)

Lester John Wu

LIN,MAO-YUAN

02-2503-5282

3F, No. 80, Sec. 1, Jianguo North Road, Zongshan Dist.Taipei , Taiwan

2024/06/18

Agent for litigious
and non-litigious matters

Tel of
Agent for litigious
and non-litigious matters

Address of
Agent for litigious
and non-litigious matters

LIN,MAO-YUAN

02-2503-5282

3F, No. 80, Sec. 1, Jianguo North Road, Zongshan Dist., Taipei 10491, Taiwan

Industry

Main Business

Biotechnology and Medical Care

(1)Gongwin Biopharm Holdings Corporation Ltd.has two subsidiaries, Gongwin Biopharm Corporation Ltd. and PTS International Incorporation. The first one is based in Taipei, Taiwan, which is engaged in cancer research, protocol designing/ conducting, manufacture process research, and market survey, being regarded as the headquarter of this corporate group. The latter one based in Texas, USA, has been conducting clinical trials in different countries. The PTS product pipelines are showed as below: ◎PTS302 applied to the therapy of lung cancer. ◎PTS100, focusing on the treatment of liver cancer. ◎PTS-02 has been approveed for orphan drug designation by USFDA . ◎PTS500, focusing on the malignant pleural effusion. (2)In near future, Gongwin will have the revenue from one of the pipelines by the licence-out model . A protocol of PTS-02 will be submitted to USFDA under the guidance of orphan drug. This is the outlook of ours.

Shr. Vol.	Highest	Lowest	Closed	Change	Transaction	TurnOver(%)	long margin balance (1,000shr.)	Short margin balance (1,000shr.)
Market Information ( 2024/07/01 )
424.582	148.50	142.50	142.50	-4.50	651		N/A	N/A
Trading method	Fun purchase price or securities pneeded on T day	Announcement of Irregularity (2024/07/01)	TPEx measures adopted (2024/07/01)		With warrants	Can be shorted or margined?	Detail
Normal	N	N	N		N	N	Today	History

Financial Reports
Cash Flows	Items
	Items	Amount (NT$ thousand)
	Cash flows from operating activities
	Cash flows from investing activities
	Cash flows from financing activities
Balance Sheets	Current assets
	Non-current assets
	Total assets
	Current liabilities
	Non-current liabilities
	Total liabilities
	Share capital
	Capital surplus
	Retained earnings
	Other equity interest
	Treasury shares
	Total equity attributable to owners of parent
	Non-controlling interests
	Total equity
	Book Value per share(NT$)
Comprehensive Income	Operating revenue
	Operating costs
	Gross profit from operations
	Operating expenses
	Net other income (expenses)
	Net operating income
	Non-operating income and expenses
	Profit before tax
	Tax expense
	Profit from continuing operations
	Profit from discontinued operations
	Profit
	Other comprehensive income
	Comprehensive income
	Basic earnings per share

Auditor's report on latest financial statements： auditor's report：

More detail:MOPS。

Foreign issuers’ information is disclosed in consolidated statements.

TOP

TPEx

Listed Companies

General Stock Board Listed Company Profile